{"_id": "23098495|None", "id": "23098495", "infons": {}, "passages": [{"infons": {"journal": "Asian Pac. J. Cancer Prev.; 2012; 13(8) 3931-6", "year": "2012", "type": "title", "authors": "Ding X, Cui FM, Xu ST, Pu JX, Huang YH, Zhang JL, Wei XD, Hou JQ, Yan CY", "section": "Title"}, "offset": 0, "text": "Variants on ESR1 and their association with prostate cancer risk: a meta-analysis.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 12, "length": 4}]}, {"id": "3", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 44, "length": 15}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 83, "text": "BACKGROUND: Epidemiological studies evaluating the association of two variants rs9340799 and rs2234693 on estrogen receptor 1 (ESR1) with prostate risk have generated inconsistent results. METHODS: A meta-analysis was here conducted to systematically evaluate the relationship of these two variants with prostate cancer susceptibility. RESULTS: For rs9340799, heterozygosity of T/C carriers showed a significant increased prostate cancer risk with a pooled odds ratio (OR) of 1.34 (95% CI = 1.06-1.69) while homozygote C/C carriers showed an increased but not statistically significant association with prostate cancer risk (pooled OR = 1.29, 95% CI = 0.94-1.79). Compared to the homozygous TT carriers, the allele C carriers showed a 31% increased risk for prostate cancer (pooled OR = 1.31, 95% CI = 1.06-1.63). No significant association between the rs2234693 and prostate cancer risk was found with the pooled OR of 1.15 (95% CI = 0.97-1.39, T/C and C/C vs. T/T) under the dominant genetic model. Compared to the homozygote T/T carriers, the heterozygous T/C carriers did not show any significantly different risk of prostate cancer (pooled OR = 1.13, 95% CI = 0.94-1.36) and the homozygous C/C carriers also did not show a significant change for prostate cancer risk compared to the wide-type T/T carriers (pooled OR = 1.26, 95% CI = 0.98-1.62). CONCLUSIONS: These data suggested that variant rs9340799, but not rs2234693, on ESR1 confers an elevated risk of prostate cancer.", "sentences": [], "annotations": [{"id": "21", "infons": {"identifier": "rs9340799", "type": "Mutation", "subtype": "SNP"}, "text": "rs9340799", "locations": [{"offset": 162, "length": 9}]}, {"id": "22", "infons": {"identifier": "rs2234693", "type": "Mutation", "subtype": "SNP"}, "text": "rs2234693", "locations": [{"offset": 176, "length": 9}]}, {"id": "23", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "estrogen receptor 1", "locations": [{"offset": 189, "length": 19}]}, {"id": "24", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 210, "length": 4}]}, {"id": "25", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 387, "length": 15}]}, {"id": "26", "infons": {"identifier": "rs9340799", "type": "Mutation", "subtype": "SNP"}, "text": "rs9340799", "locations": [{"offset": 432, "length": 9}]}, {"id": "27", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "increased prostate cancer", "locations": [{"offset": 495, "length": 25}]}, {"id": "28", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 686, "length": 15}]}, {"id": "29", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 841, "length": 15}]}, {"id": "30", "infons": {"identifier": "rs2234693", "type": "Mutation", "subtype": "SNP"}, "text": "rs2234693", "locations": [{"offset": 936, "length": 9}]}, {"id": "31", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 950, "length": 15}]}, {"id": "32", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 1204, "length": 15}]}, {"id": "33", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 1334, "length": 15}]}, {"id": "34", "infons": {"identifier": "rs9340799", "type": "Mutation", "subtype": "SNP"}, "text": "rs9340799", "locations": [{"offset": 1481, "length": 9}]}, {"id": "35", "infons": {"identifier": "rs2234693", "type": "Mutation", "subtype": "SNP"}, "text": "rs2234693", "locations": [{"offset": 1500, "length": 9}]}, {"id": "36", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 1514, "length": 4}]}, {"id": "37", "infons": {"identifier": "MESH:D011471", "type": "Disease"}, "text": "prostate cancer", "locations": [{"offset": 1547, "length": 15}]}], "relations": []}], "relations": [], "pmid": 23098495, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs2234693", "disease@MESH:D011471", "gene@2099", "mutation@rs9340799"], "journal": "Asian Pac. J. Cancer Prev.", "year": 2012, "authors": ["Ding X", "Cui FM", "Xu ST", "Pu JX", "Huang YH", "Zhang JL", "Wei XD", "Hou JQ", "Yan CY"]}
